| scholarly article | Q13442814 |
| P2093 | author name string | Shixuan Wang | |
| Jerry Y Niederkorn | |||
| Nick Hogan | |||
| Peter W Chen | |||
| Elizabeth Mayhew | |||
| Jessamee K Mellon | |||
| Yu Guang He | |||
| P2860 | cites work | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| Inhibition of T cell proliferation by macrophage tryptophan catabolism | Q28142922 | ||
| Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 | ||
| Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta | Q28209981 | ||
| Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific | Q28254589 | ||
| Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye | Q28290630 | ||
| IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism | Q33865339 | ||
| Structure--function relationships of rat hepatic tryptophan 2,3-dioxygenase: identification of the putative heme-ligating histidine residues | Q34084855 | ||
| Uveal melanoma: epidemiologic aspects | Q34555934 | ||
| Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. | Q34768412 | ||
| Immune privilege in the anterior chamber of the eye. | Q34788773 | ||
| Inhibition of experimental asthma by indoleamine 2,3-dioxygenase | Q35835456 | ||
| Metastatic uveal melanoma therapy: current options | Q36347378 | ||
| Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. | Q36376561 | ||
| Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites | Q36376598 | ||
| See no evil, hear no evil, do no evil: the lessons of immune privilege | Q36426813 | ||
| Cellular and molecular mechanisms of liver tolerance | Q36593734 | ||
| Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer | Q36612457 | ||
| The role of indoleamine 2,3-dioxygenase in transplantation | Q36713343 | ||
| Epidemiologic aspects of uveal melanoma | Q39632521 | ||
| Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. | Q40247859 | ||
| Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients | Q40257073 | ||
| Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. | Q40314157 | ||
| Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression | Q40315535 | ||
| Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite | Q40354381 | ||
| Regulation of indoleamine 2,3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens. Relevance for senile nuclear cataract. | Q40893356 | ||
| Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma | Q40974941 | ||
| Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. | Q41675605 | ||
| Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. | Q43867525 | ||
| Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. | Q43950657 | ||
| Lymphocytic infiltration in uveal malignant melanoma | Q44729354 | ||
| Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma | Q44746132 | ||
| Transforming growth factor-beta in human aqueous humor | Q44803554 | ||
| Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance | Q44829417 | ||
| Induction of indoleamine 2,3-dioxygenase in tumor cells transplanted into allogeneic mouse: interferon-gamma is the inducer. | Q45899170 | ||
| Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine | Q47422096 | ||
| Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege | Q47937110 | ||
| Effects of experimental ocular inflammation on ocular immune privilege. | Q50125262 | ||
| Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. | Q50515728 | ||
| Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. | Q53665348 | ||
| Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. | Q54488060 | ||
| High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells | Q57729536 | ||
| Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100 | Q58235005 | ||
| Accessory cell function of human melanoma cells in mitogen-induced T cell proliferation | Q68097897 | ||
| Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness | Q69880388 | ||
| Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye | Q71020244 | ||
| Indoleamine 2,3-dioxygenase activity in the aqueous humor, iris/ciliary body, and retina of the bovine eye | Q72566899 | ||
| Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma | Q72816439 | ||
| Melanomas that develop within the eye inhibit lymphocyte proliferation | Q73923165 | ||
| Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells | Q77899643 | ||
| Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation | Q79283574 | ||
| 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms | Q80087479 | ||
| Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? | Q82993703 | ||
| P433 | issue | 5 | |
| P921 | main subject | uveal melanoma | Q356372 |
| P304 | page(s) | 617-625 | |
| P577 | publication date | 2007-07-25 | |
| P1433 | published in | Experimental Eye Research | Q15754753 |
| P1476 | title | Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion | |
| P478 | volume | 85 |
| Q35079709 | Biology of advanced uveal melanoma and next steps for clinical therapeutics |
| Q61447146 | Differential modulation and prognostic values of immune-escape genes in uveal melanoma |
| Q46515186 | Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy! |
| Q92503867 | HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target |
| Q36863359 | Identification of an Immunogenic Subset of Metastatic Uveal Melanoma |
| Q37535138 | Immune escape mechanisms of intraocular tumors |
| Q92256915 | Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy? |
| Q38783820 | Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies |
| Q36866163 | Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer |
| Q83150387 | Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma |
| Q37522460 | Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases |
| Q26747534 | Ocular diseases: immunological and molecular mechanisms |
| Q42200330 | Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? |
| Q36769330 | PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro |
| Q37742632 | The biology of uveal melanoma |
| Q37329058 | The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer |
| Q38783505 | Update on Metastatic Uveal Melanoma: Progress and Challenges. |
| Q37981069 | Uveal melanoma: the inflammatory microenvironment. |
Search more.